Authors : Manimozhi Kumaraswamy; Gokul Sathasivam; Jayasri Jayabalan; Akshaya Kumar; Rubasri Asaithambi; Balachandru Velmurugan

Volume/Issue : Volume 10 - 2025, Issue 10 - October

Google Scholar : https://tinyurl.com/yzhz2x8k

Scribd : https://tinyurl.com/bd2yv5v9

DOI : https://doi.org/10.38124/ijisrt/25oct523

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : ODTs are solid dosage forms that break down or dissolve quickly in the mouth without water. Orodispersible tablets(ODTs) have changed how we administer drugs, especially for children, elderly patients, and those who have difficulty swallowing. The arrival of 3D printing has improved the possibilitiesfor ODTs by allowing precise control over drug dosage, shape, and release profiles. Thissupportsthe idea of tailored therapy. The printed formulation meets patient goals by providing the right dose based on individual needs and drug release patterns. Recently, 3D printing has emerged in pharmaceutical development, offering a chance to move away from standardized medication dosing and toward more precise and personalized treatments. Many technologies have beendeveloped inthe pharmaceuticalfield, butfew offer the same advantages as 3D printing. This review looks at the latest advancements in 3D printing techniques for creating ODTs. It emphasizes different printing methods, formulation strategies, excipient choices, and regulatory issues. The article also discusses the challenges and future paths for clinical use and commercial implementation.

Keywords : 3D Printing, Orodispersible Tablets, Personalized Medicine, Fused Deposition Modeling, Inkjet Printing, Additive Manufacturing, Drug Delivery.

References :

1. Commission for the European Pharmacopoeia. Council of Europe, Strasbourg, 2020. European Pharmacopoeia 10.0. Monograph on Orodispersible Tablet(01/2008:1165).
2. Food and Drug Administration (FDA) of the United States.(2008) Industry Recommendations: Oral Tablet Disintegration. CDER, Rockville, MD.
3. Patel, V., Deshmukh, K. R., & Maru, A. (2021). An overview of current developments in drug delivery using orodispersible tablets. 71(2), 21–27, International Journal of Pharmaceutical Sciences Review and Research.
4. Parkash, V., & Kumar, P. (2011). Fast disintegrating tablets: Opportunity in drug delivery. Journal of Advanced Pharmaceutical Technology & Research, 2(4), 223-235.
5. Yu, D. G., Yang, X. L., Li, X. L., Branford-White, C., Ma, Z. H., and Zhu, L. M. (2009). innovative drug delivery systems that use 3D extrusion printing to create linear release profiles. 168–174 in Journal of Controlled Release, 148(2).
6. Wang, J., Goyanes, A., Buanz, A., Telford, R., Gaisford, S., Martinez-Pacheco, R., & Basit, A. W. (2015). 3D printing pharmaceuticals: creating innovative oral drug forms. 234, 137–144; Journal of Controlled Release.
7. Moore, C. M. V., Khan, M. A., Norman, J., Madurawe, R. D., & Khairuzzaman, A. (2017). 3D-printed medication products represent a new era in pharmaceutical manufacturing. Reviews on Advanced Drug Delivery, 108, 39–50.
8. Stucker, B., Rosen, D., & Gibson, I. (2021). 3D printing, rapid prototyping, and direct digital manufacturing are examples of additive manufacturing technologies (3rd ed.).
9. Dimov, S. S. and D. T. Pham (2001). Rapid Manufacturing: Rapid Tooling and Rapid Prototyping Technologies and Uses.
10. Kristiawan, R. B., Imaduddin, F., Ariawan, D., Sabino, U., & Arifin, Z. (2021). A review on the fused deposition modeling (FDM) 3D printing: Filament processing, materials, and printing parameters. Open Engineering, 11(1).
11. Cano-Vicent, A., Pérez-García, R., Crespo, J. E., & García-Martínez, J. M. (2021). Fused deposition modelling: Current status, methodology and applications. Additive Manufacturing, 47, 102278.
12. Melches F. P., Feijen, J., & Grijpma, D. W. (2010) A review on stereolithography and its applications in biomedical engineering.Biomaterials, 31(24), 6121–6130.
13. Jacobs, P. F. (1992) Rapid Prototyping & Manufacturing: Fundamentals of Stereolithography.
14. Pioneering Work in DPE Goyanes, A., Allahham, N., Trenfield, S. J., Stoyanov, E. V., Gaisford, S., & Basit, A. W. (2019). International Journal of Pharmaceutics, 567, 118471.
15. Systematic Review of DPEAguilar-de-Leyva, A., Casas, M., Ferrero, C., Linares, V.,&Caraballo,I.(2024).Pharmaceutics,16(4),437.
16. Technical Parameters from Practical Implementation Trenfield, S. J., Awad, A., Goyanes, A., Gaisford, S., & Basit, A. W. (2018).
17. Ghourichay, M. P., Kiaie, S. H., Nokhodchi, A., & Javadzadeh, Y. (2021). Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives. Biomed Research International.
18. Saleh-Bey-Kinj, Z., Heller, Y., Socratous, G., & Christodoulou, P. (2025). 3D Printing in Oral Drug Delivery: Technologies, Clinical Applications and Future Perspectives in Precision Medicine. Pharmaceuticals, 18(7), 973.
19. Sandri et al., 2019 - ODTs in Pediatric and Geriatric Care Sandri, G., Rossi, S., & Bonferoni, M. C. (2019). Disintegrating tablets: A modern approach to patient-centric drug delivery. Expert Opinion on Drug Delivery, 16(11), 1051–1062.
20. Foundational Review of Volumetric Additive Manufacturing
21. Ferraro, P., et al. (2024). Volumetric additive manufacturing: A new frontier in layer-less 3D printing. Additive Manufacturing, 84, Article 104094.
22. Volumetric Fabrication via Holographic Light Fields Kelly, B. E., et al. (2019). Volumetric additive manufacturing via tomographic reconstruction. Science.
23. Musazzi, U. M., et al. (2020). Advances in multi-material 3D printing for oral drug delivery: Combining FDM and SLS for complex dosage forms.Pharmaceutics, 12(12), 1185.
24. Thakkar, R., Pillai, S., Zhang, J., & Billa, N. (2023). Effect of infill density on drug release from 3D printed tablets fabricated via fused deposition modeling. Pharmaceutical Research, 40(1), 55–68.
25. Sun, Y., Soh, S., & Gaisford, S. (2023). Multi-material 3D printing in pharmaceuticals: Progress and potential for personalised polypills. Advanced Drug Delivery Reviews, 198, 114903. https://doi.org/10.1016/j.addr.2023.114903
26. Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. New England Journal of Medicine, 372(9), 793–795.